THE LEGAL SAGA OVER THE ABORTION PILL MIFEPRISTONE CONTINUES —
NOW THE SUPREME COURT IS GUARANTEED TO HAVE THE FINAL SAY.
THE LATEST RULING COMING FROM A FEDERAL APPEALS COURT WEDNESDAY —
WANTING ACCESS TO THE PILL TO BE **LIMITED —
AFTER FINDING THE F-D-A OVERSTEPPED ITS AUTHORITY IN THREE WAYS —
BY ALLOWING THE DRUG TO BE TAKEN LATE IN PREGNANCY —
ALLOWING THE DRUG TO BE **MAILED DIRECTLY TO PATIENTS.
AND HAVING MEDICAL PROFESSIONALS OTHER THAN DOCTORS PRESCRIBE THE PILL TO WOMEN SEEKING ABORTIONS.
WHILE THE RULING SEEKS TO LIMIT ACCESS TO MIFEPRISTONE —
FOR NOW — ACCESS WILL REMAIN **UNCHANGED.
THE JUSTICE DEPARTMENT SAID IT WILL GO BACK TO THE SUPREME COURT TO APPEAL THIS LATEST RULING —
WHICH SETS THE HIGH COURT UP FOR A FINAL VOTE ON THE MATTER.
Tags: Abortion, abortion pills, FDA, Joe Biden, Kamala Harris, Mifepristone, New Orleans, Supreme Court, U.S. Food and Drug Administration